Cyclooxygenase-2 overexpression associated with a poor prognosis in chondrosarcomas

Makoto Endo, Tadaki Matsumura, Takehiko Yamaguchi, Umio Yamaguchi, Yuki Morimoto, Fumihiko Nakatani, Akira Kawai, Hirokazu Chuman, Yasuo Beppu, Tadakazu Shimoda, Tadashi Hasegawa

Research output: Contribution to journalArticlepeer-review

24 Citations (Scopus)


Recent studies have shown increased levels of cyclooxygenase (COX)-2 in various human malignancies, including some bone and soft tissue tumors, but little is known about the presence of COX-2 in chondrosarcomas. We performed immunohistochemical staining for COX-2 in 74 chondrosarcomas and compared the staining results with the characteristics and outcome of the patients. Thirty-seven men and 37 women between the ages of 14 and 81 years (median, 50 years) participated in the study. The tumors were located in the axial skeleton in 47 cases and in the long bones in 27 cases. The largest diameters of the tumors ranged from 2.7 to 32 cm (median, 8.0 cm). The immunohistochemistry findings revealed the overexpression of COX-2 in 16 (22%) of the 74 patients. Thirteen (41%) of 32 grade 2 and 2 (67%) of 3 grade 3 chondrosarcomas showed overexpression for COX-2, whereas only 1 (3%) of 39 grade 1 chondrosarcomas showed overexpression. Overexpression of COX-2 was significantly associated with histologic grade (P < .001) and a decreased disease-specific survival (P < .001). These findings suggest that COX-2 overexpression in chondrosarcoma is a negative prognostic factor that may be strongly associated with histologic grade.

Original languageEnglish
Pages (from-to)471-476
Number of pages6
JournalHuman Pathology
Issue number4
Publication statusPublished - Apr 2006
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine


Dive into the research topics of 'Cyclooxygenase-2 overexpression associated with a poor prognosis in chondrosarcomas'. Together they form a unique fingerprint.

Cite this